» Articles » PMID: 36901115

Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight

Overview
Publisher MDPI
Date 2023 Mar 11
PMID 36901115
Authors
Affiliations
Soon will be listed here.
Abstract

Excess weight, smoking and risky drinking are preventable risk factors for colorectal cancer (CRC). However, several studies have reported a protective association between aspirin and the risk of CRC. This article looks deeper into the relationships between risk factors and aspirin use with the risk of developing CRC. We performed a retrospective cohort study of CRC risk factors and aspirin use in persons aged >50 years in Lleida province. The participants were inhabitants with some medication prescribed between 2007 and 2016 that were linked to the Population-Based Cancer Registry to detect CRC diagnosed between 2012 and 2016. Risk factors and aspirin use were studied using the adjusted HR (aHR) with 95% confidence intervals (CI) using a Cox proportional hazard model. We included 154,715 inhabitants of Lleida (Spain) aged >50 years. Of patients with CRC, 62% were male (HR = 1.8; 95% CI: 1.6-2.2), 39.5% were overweight (HR = 2.8; 95% CI: 2.3-3.4) and 47.3% were obese (HR = 3.0; 95% CI: 2.6-3.6). Cox regression showed an association between aspirin and CRC (aHR = 0.7; 95% CI: 0.6-0.8), confirming a protective effect against CRC and an association between the risk of CRC and excess weight (aHR = 1.4; 95% CI: 1.2-1.7), smoking (aHR = 1.4; 95% CI: 1.3-1.7) and risky drinking (aHR = 1.6; 95% CI: 1.2-2.0). Our results show that aspirin use decreased the risk of CRC and corroborate the relationship between overweight, smoking and risky drinking and the risk of CRC.

Citing Articles

Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer.

Marino P, Mininni M, Deiana G, Marino G, Divella R, Bochicchio I Nutrients. 2024; 16(6).

PMID: 38542712 PMC: 10974142. DOI: 10.3390/nu16060800.

References
1.
Movahedi M, Bishop D, Macrae F, Mecklin J, Moeslein G, Olschwang S . Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study. J Clin Oncol. 2015; 33(31):3591-7. DOI: 10.1200/JCO.2014.58.9952. View

2.
Coyle C, Cafferty F, Langley R . Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?. Curr Colorectal Cancer Rep. 2016; 12:27-34. PMC: 4786609. DOI: 10.1007/s11888-016-0306-9. View

3.
Shaukat A, Dostal A, Menk J, Church T . BMI Is a Risk Factor for Colorectal Cancer Mortality. Dig Dis Sci. 2017; 62(9):2511-2517. DOI: 10.1007/s10620-017-4682-z. View

4.
Nolen S, Evans M, Fischer A, Corrada M, Kawas C, Bota D . Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review. Mech Ageing Dev. 2017; 164:113-126. PMC: 7788911. DOI: 10.1016/j.mad.2017.05.002. View

5.
Brasky T, Potter J, Kristal A, Patterson R, Peters U, Asgari M . Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control. 2012; 23(3):431-44. PMC: 3319091. DOI: 10.1007/s10552-011-9891-8. View